Literature DB >> 3002345

Cryptic urokinase binding sites on human foreskin fibroblasts.

A Bajpai, J B Baker.   

Abstract

Human foreskin cells possess sites on their surfaces that specifically bind both active and diisopropylphosphofluoridate-inactivated 2 chain 54 K Da [125I]-urokinase, but do not bind the 54 K Da single chain form of urokinase. 125I-urokinase bound to these sites is not internalized and is very slow to dissociate. There are about 40,000 available binding sites per cell. Brief incubation with pH 2.5 buffer at 5 degrees C unmasks another two to six fold more sites and also extracts plasminogen activator that, based on its accessibility to trypsin, appears to be at the cell surface. This suggests that the cryptic urokinase binding sites could be sites occupied with endogenous plasminogen activator.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3002345     DOI: 10.1016/0006-291x(85)90931-3

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

1.  Isolation and characterization of cell lines with reduced urokinase binding.

Authors:  H K Lau; J M Teitel; M Kim
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

2.  Regulation of plasminogen receptor expression on human monocytes and monocytoid cell lines.

Authors:  J Felez; L A Miles; J Plescia; E F Plow
Journal:  J Cell Biol       Date:  1990-10       Impact factor: 10.539

3.  Plasminogen activation in healing human wounds.

Authors:  B M Schäfer; K Maier; U Eickhoff; R F Todd; M D Kramer
Journal:  Am J Pathol       Date:  1994-06       Impact factor: 4.307

4.  Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin.

Authors:  W C Darbonne; G C Rice; M A Mohler; T Apple; C A Hébert; A J Valente; J B Baker
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

5.  Assignment of the urokinase-type plasminogen activator receptor gene (PLAUR) to chromosome 19q13.1-q13.2.

Authors:  A D Børglum; A Byskov; P Ragno; A L Roldan; P Tripputi; G Cassani; K Danø; F Blasi; L Bolund; T A Kruse
Journal:  Am J Hum Genet       Date:  1992-03       Impact factor: 11.025

6.  Pericellular proteolysis by leukocytes and tumor cells on substrates: focal activation and the role of urokinase-type plasminogen activator.

Authors:  Andrei L Kindzelskii; Imran Amhad; Donald Keller; M-J Zhou; Richard P Haugland; B A Garni-Wagner; Margaret R Gyetko; Robert F Todd; Howard R Petty
Journal:  Histochem Cell Biol       Date:  2004-03-20       Impact factor: 4.304

7.  A high-affinity receptor for urokinase plasminogen activator on human keratinocytes: characterization and potential modulation during migration.

Authors:  H McNeill; P J Jensen
Journal:  Cell Regul       Date:  1990-10

8.  The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes.

Authors:  A Estreicher; J Mühlhauser; J L Carpentier; L Orci; J D Vassalli
Journal:  J Cell Biol       Date:  1990-08       Impact factor: 10.539

9.  Regulation of urokinase receptors in monocytelike U937 cells by phorbol ester phorbol myristate acetate.

Authors:  R Picone; E L Kajtaniak; L S Nielsen; N Behrendt; M R Mastronicola; M V Cubellis; M P Stoppelli; S Pedersen; K Danø; F Blasi
Journal:  J Cell Biol       Date:  1989-02       Impact factor: 10.539

10.  Urokinase-receptor biosynthesis, mRNA level and gene transcription are increased by transforming growth factor beta 1 in human A549 lung carcinoma cells.

Authors:  L R Lund; J Rømer; E Rønne; V Ellis; F Blasi; K Danø
Journal:  EMBO J       Date:  1991-11       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.